Viewing StudyNCT00386139



Ignite Creation Date: 2024-05-05 @ 5:06 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00386139
Status: COMPLETED
Last Update Posted: 2017-02-07
First Post: 2006-10-09

Brief Title: A Safety and Efficacy Trial of the Combination of Aliskiren Hydrochlorothiazide HCTZ300125 mg and 30025 mg Compared to Aliskiren 300 mg in Hypertensive Patients
Sponsor: Novartis
Organization: Novartis

Organization Data

Organization: Novartis
Class: INDUSTRY
Study ID: CSPP100A2332
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novartis
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators